1. Home
  2. RGTIW vs SNY Comparison

RGTIW vs SNY Comparison

Compare RGTIW & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGTIW
  • SNY
  • Stock Information
  • Founded
  • RGTIW 2013
  • SNY 1994
  • Country
  • RGTIW United States
  • SNY France
  • Employees
  • RGTIW 140
  • SNY N/A
  • Industry
  • RGTIW Retail: Computer Software & Peripheral Equipment
  • SNY Biotechnology: Pharmaceutical Preparations
  • Sector
  • RGTIW Technology
  • SNY Health Care
  • Exchange
  • RGTIW Nasdaq
  • SNY Nasdaq
  • Market Cap
  • RGTIW N/A
  • SNY 113.4B
  • IPO Year
  • RGTIW N/A
  • SNY N/A
  • Fundamental
  • Price
  • RGTIW $9.77
  • SNY $47.02
  • Analyst Decision
  • RGTIW
  • SNY Buy
  • Analyst Count
  • RGTIW 0
  • SNY 4
  • Target Price
  • RGTIW N/A
  • SNY $61.50
  • AVG Volume (30 Days)
  • RGTIW 850.8K
  • SNY 2.7M
  • Earning Date
  • RGTIW 03-11-2025
  • SNY 10-24-2025
  • Dividend Yield
  • RGTIW N/A
  • SNY 3.41%
  • EPS Growth
  • RGTIW N/A
  • SNY 118.56
  • EPS
  • RGTIW N/A
  • SNY 8.65
  • Revenue
  • RGTIW $11,892,000.00
  • SNY $53,714,621,258.00
  • Revenue This Year
  • RGTIW N/A
  • SNY $1.53
  • Revenue Next Year
  • RGTIW N/A
  • SNY $7.06
  • P/E Ratio
  • RGTIW N/A
  • SNY $5.42
  • Revenue Growth
  • RGTIW N/A
  • SNY 15.65
  • 52 Week Low
  • RGTIW $4.28
  • SNY $44.73
  • 52 Week High
  • RGTIW $4.75
  • SNY $60.12
  • Technical
  • Relative Strength Index (RSI)
  • RGTIW N/A
  • SNY 43.22
  • Support Level
  • RGTIW N/A
  • SNY $46.50
  • Resistance Level
  • RGTIW N/A
  • SNY $47.69
  • Average True Range (ATR)
  • RGTIW 0.00
  • SNY 0.67
  • MACD
  • RGTIW 0.00
  • SNY -0.18
  • Stochastic Oscillator
  • RGTIW 0.00
  • SNY 36.70

About RGTIW Rigetti Computing Inc.

Rigetti Computing Inc is engaged in the business of full-stack quantum computing. The company offers full-stack quantum computing platform as a cloud service to a wide range of end-users, directly through its Rigetti QCS platform, and also through cloud service providers. Its proprietary quantum-classical infrastructure provides ultra-low latency integration with public and private clouds for high-performance practical quantum computing. The company has developed the industry's first multi-chip quantum processor for scalable quantum computing systems. Geographically, the company derives the majority of its revenue from the United States.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: